In the GOAL study, [23] increasing the ICS dose in ICS + LABA combinations (fluticasone proprionate + salmeterol) for 1-year duration improved asthma control, which included a short oral ...
Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg ... Available data show that when ICS and LABA are used together, such as with Advair HFA, there is not a significant increase ...
Seretide/Advair (fluticasone propionate + salmeterol; GlaxoSmithKline) and Symbicort (budesonide + formoterol fumarate dihydrate; AstraZeneca), which are ICS–LABA combinations, are other popular ...
Fluticasone propionate ... intubations) with LABA monotherapy (without ICS). Do not initiate in rapidly or acutely deteriorating asthma. Not for use with other long-acting β 2-agonists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback